Skip to main navigation Skip to search Skip to main content

Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain

  • Ping Han Huang
  • , Hsiao Han Tsai
  • , Bo Hung Liao
  • , Yi Ling Lin
  • , Jia Tsrong Jan
  • , Mi Hua Tao
  • , Yu Chi Chou
  • , Che Ming Jack Hu
  • , Hui Wen Chen

Research output: Contribution to journalComment/debatepeer-review

Abstract

A safe and effective vaccine candidate is urgently needed for the ongoing COVID-19 pandemic, caused by SARS-CoV-2. Here we report that recombinant SARS-CoV-2 RBD protein immunization in mice is able to elicit a strong antibody response and potent neutralizing capability as measured using live or pseudotyped SARS-CoV-2 neutralization assays.

Original languageEnglish (US)
Pages (from-to)654-655
Number of pages2
JournalHuman Vaccines and Immunotherapeutics
Volume17
Issue number3
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • SARS-CoV-2
  • neutralizing antibodies
  • receptor-binding domain
  • vaccine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain'. Together they form a unique fingerprint.

Cite this